Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

43.73
Delayed Data
As of 4:01pm ET
 +0.57 / +1.32%
Today’s Change
36.76
Today|||52-Week Range
45.84
+13.85%
Year-to-Date

Today’s Trading

Previous close43.16
Today’s open43.14
Day’s range43.10 - 43.87
Volume5,802,308
Average volume (3 months)7,405,359
Market cap$74.9B
Dividend yield2.42%
Data as of 4:01pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+12.43%
Earnings growth (next 5 years)+10.95%
Revenue growth (last year)+2.20%
P/E ratio49.1
Price/Sales2.73
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+0.39+0.18%
NVONovo Nordisk+0.65+1.59%
AZNAstraZeneca+0.05+0.15%
LLYEli Lilly and Co-0.82-1.05%
Data as of 4:02pm ET, 05/22/2017

Financials

Next reporting dateJuly 19, 2017
EPS forecast (this quarter)$0.60
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts